{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:27:33Z","timestamp":1791559653423,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["LRP 1 L30 CA231572-01"],"award-info":[{"award-number":["LRP 1 L30 CA231572-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2018-2022"],"award-info":[{"award-number":["2018-2022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CSDG-20-013-01-CCE"],"award-info":[{"award-number":["CSDG-20-013-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canep.2025.102815","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T23:23:13Z","timestamp":1745450593000},"page":"102815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Epidemiology of carcinomatosis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8847-4726","authenticated-orcid":false,"given":"Kyle A.","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5822-171X","authenticated-orcid":false,"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-7041","authenticated-orcid":false,"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1455-6758","authenticated-orcid":false,"given":"Richard S.","family":"Hoehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-1986","authenticated-orcid":false,"given":"Nicholas G.","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.canep.2025.102815_bib1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br. J. Surg. [Internet]"},{"key":"10.1016\/j.canep.2025.102815_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canep.2025.102815_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.critrevonc.2019.01.020","article-title":"Leptomeningeal carcinomatosis in patients with breast cancer","volume":"135","author":"Franzoi","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"39","key":"10.1016\/j.canep.2025.102815_bib4","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence, prognosis and treatment options","volume":"18","author":"Klaver","year":"2012","journal-title":"World J. Gastroenterol.: WJG [Internet]"},{"issue":"2","key":"10.1016\/j.canep.2025.102815_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","article-title":"Leptomeningeal carcinomatosis","volume":"25","author":"Grossman","year":"1999","journal-title":"Cancer Treat. Rev. [Internet]"},{"issue":"10","key":"10.1016\/j.canep.2025.102815_bib6","article-title":"Immunotherapy in pancreatic cancer: why do we keep failing? A focus on tumor immune microenvironment, predictive biomarkers and treatment outcomes","volume":"14","author":"Di Federico","year":"2022","journal-title":"Cancers (Basel) [Internet]"},{"issue":"10","key":"10.1016\/j.canep.2025.102815_bib7","article-title":"Prognostic significance of the Royal Marsden Hospital (RMH) score in patients with cancer: a systematic review and meta-analysis","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel) [Internet]"},{"issue":"12","key":"10.1016\/j.canep.2025.102815_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","article-title":"Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study","volume":"17","author":"Rizzo","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol. [Internet]"},{"issue":"12","key":"10.1016\/j.canep.2025.102815_bib9","article-title":"Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data","volume":"31","author":"Guven","year":"2023","journal-title":"Support Care Cancer [Internet]"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.euf.2021.01.003","article-title":"Expression of programmed cell death ligand 1 as a predictive biomarker in metastatic urothelial carcinoma patients treated with first-line immune checkpoint inhibitors versus chemotherapy: a systematic review and meta-analysis","volume":"8","author":"Rizzo","year":"2022","journal-title":"Eur. Urol. Focus [Internet]"},{"issue":"12","key":"10.1016\/j.canep.2025.102815_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/DCR.0b013e3182a62d9d","article-title":"Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin","volume":"56","author":"Thomassen","year":"2013","journal-title":"Dis. Colon Rectum [Internet]"},{"issue":"11","key":"10.1016\/j.canep.2025.102815_bib12","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J. Cancer [Internet]"},{"issue":"8","key":"10.1016\/j.canep.2025.102815_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","article-title":"Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study","volume":"58","author":"Quere","year":"2015","journal-title":"Dis. Colon Rectum [Internet]"},{"issue":"2","key":"10.1016\/j.canep.2025.102815_bib14","first-page":"e41","article-title":"Bevacizumab in addition to palliative chemotherapy for patients with peritoneal carcinomatosis of colorectal origin: a nationwide population-based study","volume":"15","author":"Razenberg","year":"2016","journal-title":"Clin. Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.canep.2025.102815_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/bjs.10521","article-title":"Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis","volume":"104","author":"Grass","year":"2017","journal-title":"Br. J. Surg. [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib16","first-page":"283","article-title":"Looking up: recent advances in understanding and treating peritoneal carcinomatosis","volume":"65","author":"Lambert","year":"2015","journal-title":"CA Cancer J. Clin. [Internet]"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib17","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol. [Internet]"},{"issue":"33","key":"10.1016\/j.canep.2025.102815_bib18","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized Phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J. Clin. Oncol. [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.currproblcancer.2012.03.011","article-title":"Limitations and biases of the surveillance, epidemiology, and end results database","volume":"36","author":"Park","year":"2012","journal-title":"Curr. Probl. Cancer [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.currproblcancer.2012.03.007","article-title":"Overview of the surveillance, epidemiology, and end results database: evolution, data variables, and quality assurance","volume":"36","author":"Park","year":"2012","journal-title":"Curr. Probl. Cancer [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.semradonc.2023.06.003","article-title":"Real-world data: applications and relevance to cancer clinical trials","volume":"33","author":"Gross","year":"2023","journal-title":"Semin Radiat. Oncol. [Internet]"},{"key":"10.1016\/j.canep.2025.102815_bib22","doi-asserted-by":"crossref","unstructured":"Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., et al. Peritoneal Carcinomatosis from Non-Gynecologic Malignancies Results of the EVOCAPE 1 Multicentric Prospective Study. 2000 [cited 2023 Jul 19]; Available from: https:\/\/onlinelibrary.wiley.com\/terms-and-conditions.","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"issue":"11","key":"10.1016\/j.canep.2025.102815_bib23","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J. Cancer [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib24","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0016-5085(97)70119-7","article-title":"The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation","volume":"112","author":"Shepherd","year":"1997","journal-title":"Gastroenterol. [Internet]"},{"key":"10.1016\/j.canep.2025.102815_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/BF02048443","article-title":"Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis","author":"Sugarbaker","year":"1994","journal-title":"Dis. Colon Rectum [Internet]"},{"key":"10.1016\/j.canep.2025.102815_bib26","doi-asserted-by":"crossref","unstructured":"Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., et al. Peritoneal Carcinomatosis from Non-Gynecologic Malignancies Results of the EVOCAPE 1 Multicentric Prospective Study. 2000 [cited 2023 Jul 19]; Available from: https:\/\/onlinelibrary.wiley.com\/terms-and-conditions.","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1470-2045(08)70335-8","article-title":"Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment","volume":"10","author":"Ceelen","year":"2009","journal-title":"Lancet Oncol. [Internet]"},{"key":"10.1016\/j.canep.2025.102815_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101760","article-title":"Epidemiology of liver metastases","volume":"67","author":"Horn","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2025.102815_bib29","unstructured":"Pavlidis N. The diagnostic and therapeutic management of leptomeningeal carcinomatosis. [cited 2023 Jul 20]; Available from: http:\/\/annonc.oxfordjournals.org\/."},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jocn.2014.10.022","article-title":"Treatment of leptomeningeal carcinomatosis: Current challenges and future opportunities","volume":"22","author":"Kak","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.canep.2025.102815_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11060-011-0551-3","article-title":"Leptomeningeal disease in oligodendroglial tumors: a population-based study","volume":"104","author":"Rold\u00e1n","year":"2011","journal-title":"J. Neurooncol. [Internet]"},{"key":"10.1016\/j.canep.2025.102815_bib32","unstructured":"Ovarian Cancer Survival Rates | Ovarian Cancer Prognosis | American Cancer Society [Internet]. [cited 2023 Jul 19]. Available from: https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"issue":"26","key":"10.1016\/j.canep.2025.102815_bib33","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N. Engl. J. Med [Internet]"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J. Clin. Oncol. [Internet]"},{"issue":"20","key":"10.1016\/j.canep.2025.102815_bib36","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J. Clin. Oncol. [Internet]"},{"issue":"3","key":"10.1016\/j.canep.2025.102815_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med. [Internet]"},{"issue":"9","key":"10.1016\/j.canep.2025.102815_bib38","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann. Surg. Oncol. [Internet]"},{"issue":"4","key":"10.1016\/j.canep.2025.102815_bib39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clgc.2022.02.008","article-title":"Identification and validation of the prognostic impact of metastatic prostate cancer phenotypes","volume":"20","author":"Labe","year":"2022","journal-title":"Clin. Genitourin. Cancer [Internet]"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ijc.33744","article-title":"Pan-cancer analysis of prognostic metastatic phenotypes","volume":"150","author":"Zaorsky","year":"2022","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib41","article-title":"Future trends in incidence and long-term survival of metastatic cancer in the United States","volume":"3","author":"Hudock","year":"2023","journal-title":"Commun. Med. [Internet]"},{"issue":"1","key":"10.1016\/j.canep.2025.102815_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-45307-x","article-title":"Causes of death among people living with metastatic cancer","volume":"15","author":"Mani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canep.2025.102815_bib43","unstructured":"Number of Persons by Race and Hispanic Ethnicity for SEER Participants - SEER Registries [Internet]. [cited 2025 Feb 15]. Available from: https:\/\/seer.cancer.gov\/registries\/data.html."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212500075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212500075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:24:57Z","timestamp":1769588697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778212500075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"alternative-id":["S187778212500075X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102815","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of carcinomatosis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102815"}}